|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 417/04 | (2006.01) |
| A61K 9/14 | (2006.01) | ||
| A61K 31/47 | (2006.01) | ||
| A61K 31/4725 | (2006.01) | ||
| A61P 31/14 | (2006.01) |
| (11) | Number of the document | 2401272 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10706539.3 |
| Date of filing the European patent application | 2010-02-26 | |
| (97) | Date of publication of the European application | 2012-01-04 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-11 |
| (46) | Date of publication of the claims translation | 2017-03-27 |
| (86) | Number | PCT/EP2010/001197 |
| Date | 2010-02-26 |
| (87) | Number | WO 2010/097229 |
| Date | 2010-09-02 |
| (30) | Number | Date | Country code |
| 09153964 | 2009-02-27 | EP |
| (72) |
VAN REMOORTERE, Peter, Jozef, Maria, US
VANDECRUYS, Roger, Petrus, Gerebern, BE
DE KOCK, Herman, BE
|
| (73) |
Janssen Pharmaceuticals, Inc.,
1125 Trenton-Harbourton Road, Titusville, NJ 08560,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | HCV makrociklinio slopiklio amorfinė druska |
| AMORPHOUS SALT OF A MACROCYCLIC INHIBITOR OF HCV |
| Payment date | Validity (years) | Amount | |
| 2018-01-19 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-02-26 |